# US 6,730,701 B2 · 6-methoxy-2-naphthylacetic acid prodrugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,701 B2
- Document ID: US6730701B2
- Status: Granted
- Kind: B2
- Application number: 10/282,870
- Filed: 2002-10-29
- Published: 2003-05-29
- Granted: 2004-05-04
- Earliest claimed: 1999-10-27
- Assignees: Nobex Corporation
- Inventors: Nnochiri Nkem Ekwuribe; Jennifer A. Riggs-Sauthier
- Web page: https://patentgrep.com/patent/US6730701B2

## CPC

- A61K 31/085: having an ether linkage to aromatic ring nuclear carbon
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K 31/21: Esters, e.g. nitroglycerine, selenocyanates
- A61K 31/216: of acids having aromatic rings, e.g. benactizyne, clofibrate
- A61K 31/235: having an aromatic ring attached to a carboxyl group
- A61K 31/265: of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides compositions useful for the treatment of inflammation in humans, and related methods of treatment for the same. In one embodiment the composition is: In another embodiment, the composition is: In yet another embodiment, the composition is: Additional alternative embodiments are R or R″ are therapeutic moieties.

## Claims

### Claim 1

A pharmaceutical composition useful for treatment of inflammation in humans comprising a therapeutically effective amount of a compound of the formula:
wherein X is O or N and R is —OCH, and n is an integer from 0 to 5.

### Claim 2

A pharmaceutical composition useful for treatment of inflammation in humans comprising a therapeutically effective amount of a compound of the formula:
wherein X is O or N, and n is an integer from 2 to 3.

### Claim 3

A pharmaceutical composition useful for treatment of inflammation in humans comprising a therapeutically effective amount of a compound of the formula:
wherein X is O or N, and n is an integer from 2 to 3.

### Claim 4 (depends on 1)

The pharmaceutical composition of claim 1, wherein X is O.

### Claim 5 (depends on 1)

The pharmaceutical composition of claim 1, wherein X is N.

### Claim 6 (depends on 1)

The pharmaceutical composition of claim 1, wherein n is 0.

### Claim 7 (depends on 1)

The pharmaceutical composition of claim 1, wherein n is 1.

### Claim 8 (depends on 1)

The pharmaceutical composition of claim 1, wherein n is 2.

### Claim 9 (depends on 1)

The pharmaceutical composition of claim 1, wherein n is 3.

### Claim 10 (depends on 1)

The pharmaceutical composition of claim 1, wherein n is 4.

### Claim 11 (depends on 1)

The pharmaceutical composition of claim 1, wherein n is 5.

### Claim 12 (depends on 2)

The pharmaceutical composition of claim 2, wherein X is O.

### Claim 13 (depends on 2)

The pharmaceutical composition of claim 2, wherein X is N.

### Claim 14 (depends on 2)

The pharmaceutical composition of claim 2, wherein n is 0.

### Claim 15 (depends on 2)

The pharmaceutical composition of claim 2, wherein n is 2.

### Claim 16 (depends on 2)

The pharmaceutical composition of claim 2, wherein n is 3.

### Claim 17

A pharmaceutical composition useful for treatment of inflammation in humans comprising a therapeutically effective amount of a compound of the formula:
wherein X is O or N and R is —ONO2 and n is an integer from 1 to 5.

### Claim 18 (depends on 17)

The pharmaceutical composition of claim 17, wherein X is O.

### Claim 19 (depends on 17)

The pharmaceutical composition of claim 17, wherein X is N.

### Claim 20 (depends on 17)

The pharmaceutical composition of claim 17, wherein n is 1.

### Claim 21 (depends on 17)

The pharmaceutical composition of claim 17, wherein n is 2.

### Claim 22 (depends on 17)

The pharmaceutical composition of claim 17, wherein n is 3.

### Claim 23 (depends on 17)

The pharmaceutical composition of claim 17, wherein n is 4.

### Claim 24 (depends on 17)

The pharmaceutical composition of claim 17, wherein n is 5.
